-
Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk
December 17, 2018Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk to Develop Novel Treatment for Dyslipidaemia. Naarden,...
0 -
Forbion closes oversubscribed Fourth Life Sciences VC Fund at EUR 360million
October 1, 2018Naarden, The Netherlands, and Munich, Germany, 1 October 2018 – Forbion, a leading European life science venture capital firm,...
-
Climate Fund Managers and Cleantech Solar enter strategic partnership
September 13, 2018Cleantech Solar, the leading pan-Asian supplier of renewable energy to corporates has received a USD 50 million equity investment...
-
Forbion exceeds target with €270 million first close of its fourth life sciences VC fund
July 12, 2018Naarden, The Netherlands, and Munich, Germany, 11 July 2018 – Forbion, a leading European life science venture capital firm,...
-
Twelve Capital’s Market Perspective 2H 2018
July 5, 2018We are pleased to share the latest issue of Twelve Capital’s Market Perspectives with you. To download the Investment...
-
The Midas List 2018
June 5, 2018Since 2011, TrueBridge has partnered with Forbes to construct The Midas List, a ranking of the top venture capitalists...
-
Forbion participates in £29M Series B Financing of Enterprise Therapeutics to Advance its Ion Channel Modulators for the treatment of Cystic-fibrosis, COPD and severe asthma
April 12, 2018Press Release Forbion participates in £29M Series B Financing of Enterprise Therapeutics to Advance its Ion Channel Modulators for...
-
Forbion’s Portfolio Company, Prexton Therapeutics Acquired by Lundbeck for up to EUR 905 million (USD 1.1 billion)
March 16, 2018Press Release Forbion’s Portfolio Company, Prexton Therapeutics Acquired by Lundbeck for up to EUR 905 million (USD 1.1 billion)...
-
Twelve Capital’s Market Perspective 1H 2018
February 2, 2018We are pleased to share the latest issue of Twelve Capital’s Market Perspectives with you. To download the Investment...
-
TrueBridge Capital Partners closes fifth Venture Capital Fund-of-Funds at $450 million hard cap
February 1, 2018Fund V marks the firm’s fifth overscribed Venture Capital and Growth Equity Fund; maintains focus on Northern California, Early...